How the Pandemic is Reshaping the Medical Industry Chain | VB Group Interview Series Episode 4 Preview

During the more than two weeks of being confined at home by the novel coronavirus, people were subjected to a relentless barrage of massive amounts of information. During this period, VCBeat curated multiple thematic series centered on nationwide epidemic prevention efforts, aiming to provide readers with essential and objective information.Grounded in the healthcare sector and aiming to provide readers with as objective an industry forecast as possible, we have decided to relaunch [VB Group Interviews] after a two-year hiatus, inviting industry leaders to engage in real-time online discussions with our readers.

In the first episode, we invitedYu Wenxin, Chief Analyst of the Pharmaceutical Industry at Haitong SecuritiesSharing with everyone.Ms. Yu Wenxin discussed the impact of the pandemic on the pharmaceutical ecosystem. She believes that the shock to the macroeconomy caused by the pandemic was a one-time event, and the pharmaceutical industry is likely the sector least affected within the economic structure. The emergence and progression of the pandemic have made people reappreciate the paramount importance of health and raised higher demands for the disease prevention and control system across society. This may lead to sustained increases in national-level investment in the broader health industry.

Next,Yao Feng'e, Partner and Head of Healthcare, KPMG ChinaWomen Address the Healthcare Workforce Crisis with Six Major Strategies. In the Face of Healthcare Staff Shortages,Situations where medical needs cannot be effectively met,She proposed six major strategies: strengthening primary healthcare infrastructure, empowering patients in health management, promoting digital healthcare models, exploring the application of artificial intelligence, establishing standardized diagnosis, treatment, and management systems, and showing care and support for medical personnel.

In the group interview that just concluded this Tuesday,Influencer Healthcare InvestorXiao Shan, the HeroDiscussing the Investment Logic in the Pharmaceutical and Healthcare Sector: An Analysis of the Macroeconomic Impact of the Novel Coronavirus, an Examination of the Primary and Secondary Markets Amidst the Pandemic, and a Summary of Short- and Long-Term Opportunities. In Sean Xia’s view, the industrial development cycle exhibits a trend from wild growth to differentiation, transformation, and consolidation, and finally to R&D-driven innovation; in the future, R&D innovation will become the long-term driving force for the healthcare industry.

This Thursday (2.20) at 8:00 PM, we will inviteLiu Yun, Huayi Capital, sharing with everyone the impact of the pandemic from an investor’s perspective.Click the linkhttp://shareonline.vcbeat.top/watch/4753748Or scan the QR code to join the VB Interview Series exchange group for the latest updates.

Scan the QR code to join the VB Interview Series communication group

[Topic] How the Pandemic Reshaped the Healthcare Industry Chain

[Time] February 20 (Thursday) 20:00-21:00

[Guest] Liu Yun, Founder and Chairman of Huayi Capital

Ph.D. in Venture Capital, Peking University; Master of Medicine.

Former GE Healthcare executive with 20 years of experience in the healthcare industry, spanning pharmaceuticals, medical devices, and medical consumables. Has held diverse roles in R&D, sales, and marketing, including over a decade in product management within marketing departments. Has served in nearly all core marketing positions at healthcare companies, such as Product Manager, Senior Product Manager, Product Group Manager, and Marketing Manager.

Served as a medical advisor to nearly ten fund management companies, including China Asset Management and Bosera Funds. Currently serves as an external lecturer for PwC and China Merchants Bank, and as a judge for the Forbes Under 30 Industry Elite list. Research and professional focus areas include healthcare industry economic theory, healthcare investment, and corporate strategy and integration within the healthcare sector. Representative academic work: “Eight Questions, Nine Paths,” the only academic book in China dedicated to the study of equity investment in the Chinese healthcare sector.

VB Group Interview: Every Tuesday and Thursday at 8 PM. Be there or be square! Click the linkhttp://shareonline.vcbeat.top/watch/4753748Or scan the QR code to join the VB Interview Series exchange group for the latest updates.

Scan the QR code to join the VB Group Interview Series chat group